Free Trial

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 09/11/2025

KNB vs. TLY, SPI, MGP, SBI, MHC, TCF, ODX, N4P, GENI, and GENF

Should you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), MyHealthChecked (MHC), Theracryf (TCF), Omega Diagnostics Group (ODX), N4 Pharma (N4P), GENinCode (GENI), and Genflow Biosciences (GENF). These companies are all part of the "medical" sector.

Kanabo Group vs. Its Competitors

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by company insiders. Comparatively, 24.3% of Kanabo Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.85% -11.01% -2.42%
Kanabo Group -717.63%-121.77%-20.89%

In the previous week, Totally had 3 more articles in the media than Kanabo Group. MarketBeat recorded 3 mentions for Totally and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 beat Totally's score of -0.09 indicating that Kanabo Group is being referred to more favorably in the news media.

Company Overall Sentiment
Totally Neutral
Kanabo Group Neutral

Totally has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the S&P 500.

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.00-£3.79M-£1.93-0.13
Kanabo Group£1.14M1.25-£8.18M-£0.01-15.85

Summary

Totally beats Kanabo Group on 8 of the 13 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.48B£5.84B£2.51B
Dividend YieldN/A3.83%5.68%5.30%
P/E Ratio-15.85160.5175.415,410.94
Price / Sales1.2530.97515.8196,613.70
Price / Cash1.8212.3237.5627.93
Price / Book0.241.9312.157.77
Net Income-£8.18M£58.06M£3.29B£5.89B
7 Day PerformanceN/A0.91%0.73%6.51%
1 Month PerformanceN/A-0.73%4.99%55.22%
1 Year Performance-82.69%52.82%62.53%154.12%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat
N/AN/A£1.42M£1.14M-15.8520
TLY
Totally
N/AGBX 0.25
+4.2%
N/A-97.3%£491K£133.05M-0.131,668News Coverage
Gap Down
SPI
Spire Healthcare Group
N/AGBX 212
-0.9%
GBX 294.33
+38.8%
-14.6%£853.03M£1.55B4,608.70420Positive News
High Trading Volume
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
MHC
MyHealthChecked
N/AGBX 10.29
-2.0%
N/A-14.6%£5.36M£3.61M-298.2616Gap Down
TCF
Theracryf
N/AGBX 0.25
+7.4%
N/A-64.0%£5.31MN/A-68.6110Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
N4P
N4 Pharma
N/AGBX 0.55
flat
N/A-4.4%£4.58M£7.28K-177.425Gap Up
GENI
GENinCode
N/AGBX 1.50
+7.1%
N/AN/A£4.30M£2.70M-59.292,300Gap Up
GENF
Genflow Biosciences
N/AGBX 0.85
+3.2%
N/A-60.2%£3.86MN/A-179.165Gap Up

Related Companies and Tools


This page (LON:KNB) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners